Zdrowie i gospodarka · 05/01/2005

FDA Reopens Comment Periods for Draft Guidances on QT Interval Prolongation

The FDA is extending the comment period for draft guidances on QT interval prolongation until February 18, 2005, in response to requests from stakeholders, following the International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use.